Recofast 250 Tablet

Recofast 250, belonging to the anti-infectives therapeutic class, is a medication formulated with Cefuroxime, a second-generation cephalosporin antibiotic. Each film-coated tablet of Recofast contains Cefuroxime Axetil USP, which is equivalent to 250 mg of Cefuroxime. Cefuroxime is effective against a broad range of bacteria and is used to treat various bacterial infections. It works by interfering with the formation of the bacteria's cell wall, thus leading to its rupture and death.

Recofast 250 (Cefuroxime 250 mg) is indicated for the treatment of various bacterial infections. These include respiratory tract infections like bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and infections of the ear, throat, and sinuses. It is also used in treating Lyme disease and can be prescribed as a prophylactic treatment in certain surgical procedures to prevent postoperative infections.

The dosage of Recofast 250 (Cefuroxime 250 mg) varies depending on the type and severity of the infection, as well as the patient's age and kidney function. For adults and children with normal kidney function, the typical dosage ranges from 250 mg to 500 mg twice daily, taken orally.

The tablets should be taken with food to enhance absorption. It is crucial to complete the full course of the antibiotic as prescribed, even if symptoms improve before the medication is finished, to ensure the complete eradication of the bacteria and to prevent the development of antibiotic resistance.

Patients should be advised to take the medication at evenly spaced intervals to maintain an effective level of the drug in the body. Dosage adjustments may be necessary for patients with impaired kidney function, and any changes in the treatment regimen should be made under the supervision of a healthcare professional. As with all antibiotics, patients should be informed about the importance of adhering to the prescribed dosage and duration of treatment.